Cited by 215Ubiquitin and proteasome pathwaysGenomics, phytochemicals, and oxidative stressEndoplasmic Reticulum Stress and Disease

Proteasome-mediated processing of Nrf1 is essential for coordinate induction of all proteasome subunits and p97

Open access
Sha, Zhe, Goldberg, Alfred L.·2014·Current Biology

Abstract

Background Proteasome inhibitors are widely used in the treatment of multiple myeloma and as research tools. Additionally, diminished proteasome function may contribute to neuronal dysfunction. In response to these inhibitors, cells enhance the expression of proteasome subunits by the transcription factor Nrf1. Here, we investigate the mechanisms by which decreased proteasome function triggers production of new proteasomes via Nrf1.Results Exposure of myeloma or neuronal cells to proteasome inhibitors (bortezomib, epoxomicin, and MG132), but not to proteotoxic or ER stress, caused a 2- to 4-fold increase within 4 hr in mRNAs for all 26S subunits. In addition, p97 and its cofactors (Npl4, Ufd1, and p47), PA200, and USP14 were induced, but expression of immunoproteasome-specific subunits was suppressed. Nrf1 mediates this induction of proteasomes and p97, but only upon exposure to low concentrations of inhibitors that partially inhibit proteolysis. Surprisingly, high concentrations of these inhibitors prevent this compensatory response. Nrf1 is normally ER-bound, and its release requires its deglycosylation and ubiquitination. Normally ubiquitinated Nrf1 is rapidly degraded, but when partially inhibited, proteasomes carry out limited proteolysis and release the processed Nrf1 (lacking its N-terminal region) from the ER, which allows it to enter the nucleus and promote gene expression.Conclusions When fully active, proteasomes degrade Nrf1, but when partially inhibited, they perform limited proteolysis that generates the active form of Nrf1. This elegant mechanism allows cells to compensate for reduced proteasome function by enhancing production of 26S subunits and p97.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cub.2014.06.004

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Nrf1-mediated transcriptional upregulation of the proteasome occurs during proteasome impairment to compensate for reduced proteasome function.

    “This may be explained by the Nrf1-mediated transcriptional upregulation of the proteasome during proteasome impairment to compensate for reduced proteasome function [31].”
  • Some compensation mechanisms are only observed under low concentrations of proteasome inhibitors and are absent under high levels of inhibition.

    “Interestingly, some of these compensation mechanisms are only observed under low concentrations of proteasome inhibitors, and are absent under high levels of inhibition (Sha and Goldberg, 2014)”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sha, Z., & Goldberg, A. L.
Affiliations
Harvard University (US)
Corresponding author
Goldberg, Alfred L.
Venue
Current Biology
Publisher
Elsevier BV
Published
2014-07
Volume
24
Issue
14
Pages
1573-1583
ISSN
0960-9822 (ISSN-L)
OpenAlex
W2075939049
Cited by
215
References
50
Citations by year
2026: 10 · 2025: 11 · 2024: 13 · 2023: 13 · 2022: 20 · 2021: 15 · 2020: 23 · 2019: 25 · 2018: 18 · 2017: 20 · 2016: 27 · 2015: 15 · 2014: 5
FWCI
9.11
Type
journal article
Language
en
Open access
Locations
  • Current Biology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Leukemia and Lymphoma Society
  • National Institute of General Medical Sciences (GM051923-18, R01GM051923)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
Keywords
NRF1, proteasome, VCP, proteasome inhibitors, bortezomib, epoxomicin, MG132, limited proteolysis, ubiquitination, deglycosylation, endoplasmic reticulum, compensatory response, multiple myeloma, neurons, immunoproteasome, Npl4, Ufd1, p47phox, PA200, USP14
MeSH terms
Bortezomib, Boronic Acids, Cell Line, Endoplasmic Reticulum, Humans, Leupeptins, Nuclear Proteins, Oligopeptides, Pyrazines, RNA Interference, RNA, Small Interfering, Ubiquitin Thiolesterase, Proteasome Endopeptidase Complex, Nuclear Respiratory Factor 1, Ubiquitination, Unfolded Protein Response, HEK293 Cells, Proteolysis, Proteasome Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review